Friday, July 10, 2026

pharma · Early Childhood Caries · Acute Myeloid Leukemia

University of Hong

University of Hong clinical programs — 42 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
42
Drugs
71
Patents
0
Intelligence · Clinical Programs

University of Hong projects

42 ClinicalTrials.gov programs sponsored by University of Hong.

University of Hong has 42 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 25% AgNO3 solution followed by 5% NaF

    The University of Hong Kong

    Early Childhood Caries

    phase 3 small molecule completed

    1 trial
  2. 3-second SDF application

    The University of Hong Kong

    Early Childhood Caries

    phase 3 other completed

    1 trial
  3. Acupuncture (Procedure)

    The University of Hong Kong

    Autistic Disorder

    phase 3 other completed

    1 trial
  4. Masticatory muscle training exerciser

    The University of Hong Kong

    Mastication

    phase 3 other active

    1 trial
  5. SDF solution

    The University of Hong Kong

    Dental Caries

    phase 3 other completed

    1 trial
  6. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial
  7. Atezolizumab

    The University of Hong Kong

    NSCLC Stage IIIB

    phase 2 small molecule active

    1 trial
  8. Bomedemstat

    The University of Hong Kong

    Myelofibrosis

    phase 2 small molecule active

    1 trial
  9. Capecitabine

    The University of Hong Kong

    Pancreatic Adenocarcinoma

    phase 2 small molecule completed

    1 trial
  10. Dapagliflozin 10mg Tab

    The University of Hong Kong

    Lupus Nephritis

    phase 2 small molecule active

    1 trial
  11. Decitabine

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial
  12. Dietary

    The University of Hong Kong

    Colorectal Cancer

    phase 2 other active

    1 trial
  13. Interferon Beta-1B

    The University of Hong Kong

    COVID

    phase 2 small molecule completed

    1 trial
  14. Oral arsenic trioxide

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial
  15. Traditional Chinese acupuncture

    The University of Hong Kong

    Phonotraumatic Injuries

    phase 2 other active

    1 trial
  16. pembrolizumab

    The University of Hong Kong

    T-Cell Lymphoma

    phase 2 small molecule active

    1 trial
  17. Folic Acid 5 MG

    The University of Hong Kong

    Acute Kidney Injury

    phase 1 small molecule active

    1 trial
  18. Alcohol injection

    The University of Hong Kong

    Malignancy

    approved small molecule active

    1 trial
  19. Atosiban

    The University of Hong Kong

    Subfertility

    approved small molecule completed

    1 trial
  20. Brolucizumab

    The University of Hong Kong

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial
  21. Bupivacaine Injection [Marcaine]

    The University of Hong Kong

    Acute Pain

    approved small molecule completed

    1 trial
  22. Cinacalcet

    The University of Hong Kong

    Kidney Failure

    approved small molecule completed

    1 trial
  23. Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

    The University of Hong Kong

    Fontan

    approved small molecule active

    1 trial
  24. Dexamethasone

    The University of Hong Kong

    Total Knee Replacement

    approved small molecule active

    1 trial
  25. Dexmedetomidine

    The University of Hong Kong

    Anxiety, Separation

    approved small molecule active

    1 trial
  26. Ivabradine + Usual Care

    The University of Hong Kong

    Atrial Fibrillation (Permanent)

    approved small molecule active

    1 trial
  27. Oral hygiene intervention

    The University of Hong Kong

    Acute Stroke

    approved other completed

    1 trial
  28. Paracetamol

    The University of Hong Kong

    Influenza

    approved small molecule completed

    1 trial
  29. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial
  30. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial
  31. Fluoxetine

    The University of Hong Kong

    Depression

    small molecule completed

    1 trial
  32. Inactivated influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    mab completed

    1 trial
  33. Mailed nicotine replacement therapy (NRT)

    The University of Hong Kong

    Smoking Cessation

    small molecule active

    1 trial
  34. NRT-S

    The University of Hong Kong

    Smoking Cessation

    small molecule completed

    1 trial
  35. Nicotine Replacement therapy

    The University of Hong Kong

    Smoking

    small molecule active

    1 trial
  36. Ping On Ointment

    The University of Hong Kong

    Temporomandibular Disorders

    small molecule completed

    1 trial
  37. Propofol

    The University of Hong Kong

    Anesthesia

    small molecule active

    1 trial
  38. TIV 2010/2011 influenza vaccine

    The University of Hong Kong

    Influenza

    mab completed

    1 trial
  39. TKC202505

    The University of Hong Kong

    Intracerebral Hemorrhage

    small molecule active

    1 trial
  40. UW 22-704

    The University of Hong Kong

    Recurrent Ovarian Carcinoma

    small molecule active

    1 trial
  41. indocyanine green

    The University of Hong Kong

    Anastomotic Leak

    small molecule active

    1 trial
  42. sevelamer hydrochloride

    The University of Hong Kong

    Endstage Renal Disease

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does University of Hong have?

42 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.